```html

Giant Cell Arteritis Headache

What is Giant cell arteritis headache?

Giant cell arteritis (GCA), also called temporal arteritis, is an inflammatory disease of the large‑ and medium‑sized arteries, most often affecting the branches of the external carotid artery that supply the scalp and head. A hallmark symptom is a new‑onset, persistent headache that is often described as “throbbing,” “tight,” or “pulling” around the temples.

The inflammation is caused by an abnormal immune response that leads to the formation of multinucleated giant cells in the arterial wall. This can cause the vessel to thicken, narrow, and sometimes become occluded, reducing blood flow to the tissues they supply. Because the temporal arteries lie just beneath the skin of the forehead, inflammation here is frequently felt as a headache.

GCA is most common in adults over 50 years of age, especially women of Northern European descent, and it is a medical emergency when it threatens vision or brain blood flow.

Common Causes

While “giant cell arteritis headache” itself is a symptom of GCA, several conditions can mimic or coexist with it. Knowing these helps clinicians and patients consider a broader differential diagnosis.

• Temporal arteritis (GCA) itself – the primary cause of the characteristic headache.
• Primary headache disorders – tension‑type headache or migraine can overlap, especially in older adults.
• Cluster headache – severe unilateral pain around the eye may be confused with temporal pain.
• Sinusitis or sinus infection – inflammation of the frontal or ethmoidal sinuses can produce forehead pain.
• Occipital neuralgia – irritation of the occipital nerves can radiate to the scalp and mimic GCA pain.
• Subarachnoid hemorrhage – sudden, “worst‑ever” headache; must be ruled out emergently.
• Brain tumor or metastasis – can cause persistent, progressive headache.
• Medication overuse headache – frequent analgesic use can lead to rebound pain.
• Polymyalgia rheumatica (PMR) – frequently co‑occurs with GCA and may present with headache plus shoulder/hip girdle pain.
• Infections such as meningitis – present with headache plus fever, neck stiffness, and altered mental status.

Associated Symptoms

Because GCA is a systemic vasculitis, the headache rarely appears in isolation. Typical accompanying features include:

• Scalp tenderness – especially over the temporal arteries; patients often feel pain when combing hair.
• Jaw claudication – pain or fatigue of the jaw while chewing, caused by reduced blood flow to the masseter muscles.
• Vision changes – blurry vision, transient visual loss (amaurosis fugax), or permanent vision loss due to optic nerve ischemia.
• Constitutional symptoms – low‑grade fever, night sweats, unexplained weight loss, fatigue.
• Polymyalgia rheumatica symptoms – morning stiffness and aching in the shoulders, hips, and neck.
• Feeling of “fullness” in the ear or mild hearing loss.
• Neurologic deficits – rarely, stroke‑like symptoms such as weakness or speech difficulty if cerebral arteries are involved.

When to See a Doctor

Any new, persistent headache in someone over 50 years old warrants evaluation, especially if it is accompanied by any of the following “red flag” symptoms:

• Scalp tenderness or a swollen, painful temporal artery.
• Sudden vision loss, double vision, or visual dimming.
• Jaw pain while chewing (jaw claudication).
• Fever, unexplained weight loss, or night sweats.
• Neurologic changes – weakness, numbness, difficulty speaking.
• Persistent, severe headache that does not improve with over‑the‑counter pain relievers.

Because permanent vision loss can occur within days, prompt medical attention is essential.

Diagnosis

Diagnosing GCA is a blend of clinical suspicion, laboratory testing, and imaging. No single test is definitive, but the combination yields a high diagnostic certainty.

Clinical Evaluation

• History – onset, location, character of headache; presence of scalp tenderness, jaw claudication, visual symptoms.
• Physical exam – palpation of temporal arteries for thickening, tenderness, or reduced pulsation; assessment of visual acuity and fields; evaluation for PMR‑type shoulder/hip stiffness.

Laboratory Tests

• Erythrocyte sedimentation rate (ESR) – usually markedly elevated (>50 mm/hr).
• C‑reactive protein (CRP) – another inflammatory marker, often high even when ESR is normal.
• Complete blood count (CBC) – may show anemia of chronic disease or mild leukocytosis.
• Liver function tests – occasionally abnormal in GCA.

Imaging & Procedures

• Temporal artery ultrasound – non‑invasive; shows a “halo sign” (hypoechoic circumferential wall thickening).
• MRI or CT angiography – useful for visualizing involvement of larger vessels (e.g., carotid, aortic arch).
• Temporal artery (TAB) biopsy – the gold standard. A segment of the artery is removed and examined for multinucleated giant cells, intimal hyperplasia, and inflammation. A negative biopsy does not completely exclude GCA if clinical suspicion is high.

Diagnostic Criteria

The 1990 American College of Rheumatology (ACR) criteria for GCA require at least 3 of the following:

1. Age ≥50 years at disease onset.
2. New‑onset localized headache.
3. Temporal artery abnormality (tenderness or reduced pulsation).
4. Elevated ESR ≥50 mm/hr.
5. Positive temporal artery biopsy.

Meeting these criteria predicts a >90 % likelihood of true GCA.

Treatment Options

Prompt treatment is crucial to prevent irreversible visual loss and other serious complications. Therapy is usually divided into immediate high‑dose corticosteroids, adjunctive medications, and supportive measures.

First‑Line Medical Therapy

• High‑dose oral prednisone – typically 40‑60 mg daily (≈1 mg/kg) started immediately after suspicion of GCA, even before biopsy results.
• Intravenous methyl‑prednisolone – 500‑1000 mg/day for 3 days is recommended for patients with visual symptoms or cranial ischemia.
• Symptoms usually improve within 24‑48 hours; the dose is then tapered slowly over 12‑18 months to minimize relapse and steroid side effects.

Steroid‑Sparing Agents

Long‑term high‑dose steroids carry risks (osteoporosis, diabetes, infections). Adjunctive agents help reduce the cumulative steroid burden:

• Tocilizumab (anti‑IL‑6 receptor monoclonal antibody) – FDA‑approved for GCA; shown to increase remission rates and allow faster tapering of prednisone (JAMA, 2020).
• Methotrexate – modest benefit; often used when tocilizumab is not available.
• Aspirin (low dose) – may reduce risk of ischemic complications, but should be balanced against bleeding risk.

Management of Side Effects

• Calcium (1,200 mg) + vitamin D (800–1,000 IU) plus weight‑bearing exercise to prevent osteoporosis.
• Proton‑pump inhibitor or H2 blocker if high‑dose steroids cause gastric irritation.
• Blood glucose monitoring in diabetic or pre‑diabetic patients.
• Vaccinations (influenza, pneumococcal, COVID‑19) before starting immunosuppressive therapy.

Home & Supportive Care

• Cool compresses over the temples can ease scalp tenderness.
• Avoid tight hats or headbands that may exacerbate pain.
• Stay well‑hydrated and maintain a balanced diet rich in calcium and vitamin D.
• Engage in moderate aerobic activity as tolerated; it supports cardiovascular health and bone density.

Prevention Tips

Because GCA is an autoimmune vasculitis, there is no guaranteed way to prevent it. However, certain strategies may lower the overall risk of severe complications:

• Regular medical check‑ups after age 50, especially if you have a family history of GCA or polymyalgia rheumatica.
• Control cardiovascular risk factors – hypertension, hyperlipidemia, and smoking increase arterial inflammation.
• Maintain a healthy weight and engage in regular exercise to promote vascular health.
• Vaccinate against influenza and shingles; infections can trigger inflammatory flares.
• Early reporting of new, persistent headaches or visual changes to a healthcare professional.

Emergency Warning Signs

If you experience any of the following, seek emergency care (ER or call 911) immediately:

• Sudden or progressive loss of vision in one or both eyes.
• Severe, unrelenting headache that awakens you from sleep.
• Persistent jaw pain while chewing (jaw claudication) accompanied by visual symptoms.
• Neurologic deficits such as weakness, numbness, difficulty speaking, or loss of balance.
• High fever (>38.5 °C/101.3 °F) with confusion or neck stiffness.

---

**Sources:** Mayo Clinic, CDC, National Institutes of Health (NIH), Cleveland Clinic, American College of Rheumatology, JAMA (2020) – Tocilizumab trial, WHO guidelines on vasculitis.

```